Table 1 Sociodemographic and clinical characteristics of the participants in this study.

From: Niacin skin flush and membrane polyunsaturated fatty acids in schizophrenia from the acute state to partial remission: a dynamic relationship

 

Control (n = 37)

Schizophrenia (n = 46)

 

N (%)

N (%)

Male

14 (37.8)

24 (52.2)

Smoking

6 (16.7)

22 (47.8)a

Allergy

6 (16.2)

4 (8.7)

Coffee

15 (40.5)

11 (23.9)

Drug

  

 First generation

–

6 (14.0)

 Second generation

–

22 (51.2)

 Mixed

–

15 (34.8)

PLA2G6 genotype (rs4375)b

  

 TT

19 (52.8)

23 (51.1)

 CT

15 (41.7)

19 (42.2)

 CC

2 (5.5)

3 (6.7)

 

Mean (SD)

Mean (SD)

Age

39.8 (11.8)

40.5 (10.8)

Follow-up interval (day)

72.4 (17.1)

68.8 (21.4)

Age of onset

 

23.8 (7.0)

Duration of illness

 

17.2 (10.5)

PANSS at T1 (baseline)

–

 

 Total

–

76.4 (21.2)

 Positive

–

19.8 (4.7)

 Negative

–

17.2 (8.2)

 General psychopathology

–

33.9 (10.6)

PANSS changes at T2c

–

 

 Total

–

−12.7 (16.0)d

 Positive

–

−4.9 (5.6)d

 Negative

–

−1.8 (6.2)

 General psychopathology

–

−6.0 (7.5)d

  1. ap < 0.05 by χ2 test (compared with the control group).
  2. bInformation on the genotype of one control and one patient was missing.
  3. cEight weeks after the baseline or on the first outpatient follow-up if the patient had been discharged by 8 weeks, with 26 patients having the second PANSS rating.
  4. dp < 0.05 by paired t-test (compared with the scores in the acute phase).
Back to article page